Defective adenoviruses and corresponding complementation lines

Details Defective adenoviruses and corresponding complementation lines Defective adenoviruses and corresponding complementation lines

1999-09-30

2000-10-17

Priebe, Scott D.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

4353201, 435456, 424 932, C12N 510, C12N 1534, C12N 1586

Patent

active

061330280

ABSTRACT:
Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.

REFERENCES:
patent: 4920209 (1990-04-01), Davis et al.
patent: 5670488 (1997-09-01), Gregory et al.
patent: 5700470 (1997-12-01), Saito et al.
Krougliak et al., Human Gene Therapy, 6:1575-1586 (1995).
Yeh et al., Journal of Virology, 70(1):559-565 (1996).
Wang et al., Gene Therapy, 2:775-783 (1995).
Fallaux et al., Human Gene Therapy, 9:1909-1917 (1998).
Fallaux et al., Human Gene Therapy, 7:215-222 (1996).
Senear et al., Molecular and Cellular Biology, 6(4):1253-1260 (1986).
Bernards et al., Virology, 120:422-432 (1982).
Roberts et al., Journal of Virology, 56(2):404-413 (1985).
Vaessen et al., The EMBO Journal, 5(2):335-341.
Louis et al., Virology, 186:280-285 (1992).
Chrobocek et al., Virology, 186:280-285 (1992).
Berkner, Current Topics in Microbiology and Immunology, 158:39-66 (1992).
Grable et al., Journal of Virology, 64(5):2047-2056.
Armentano et al., Human Gene Therapy, 6:1343-1353 (1995).
Klessig et al., Molecular and Cellular Biology, 4(7):1354-1362 (1984).
Engelhardt et al., Proc. Natl. Acad. Sci., 91:6196-6200 (1994).
Gao et al., Journal of Virology, 70(12):8934-8943 (1996).
Mastrangeli et al., The Journal of Clinical Investigation, Inc., 91:225-234 (1993).
Rosenfeld et al., Science, 252:431-434 (1991).
Randrainarison-Jewtoukoff et al., Biologicals, 23:145-157 (1995).
Trapnell et al., Current Opinion in Biotechnology, 5:617-625 (1994).
Lusky et al., Journal of Virology, 72(3):2022-2032 (1998).
Wang et al., Gene Therapy, 4:393-400 (1997).
LaFont et al., Lancet, 346:1442-1443 (1995).
Marshall, Science, 269:1050-1055 (1995).
Miller et al., FASEBJ, 9:190-199 (1995).
Culver et al., TIG, 10(5):174-178 (1994).
Hodgson, Exp. Opin. Ther. Pat., 5(5):459-468 (1995).
Berkner et al., Biotechniques, 6(7):616-628 (1988).
Weinberg et al., Proc. Nat. Acad. Sci., 80:5383-5386 (1993).
Bajocchi et al., Nature Genetics, 3:229-234 (1993).
James et al., Antiviral Chem. Chemo., 2(4):191-214 (1991).
Babiss, Journal of Virology, 63(6):2709-2717 (1989).
Statford-Perricaudet et al., Human Gene Transfer,219:51-61 (1991).
Rosenfeld et al., Cell, 68(1):143-155 (1992).
Imler et al., Gene Therapy, 3:75-84 (1996).
Bellon et al., Human Gene Therapy, 8:15-25 (1997).

Affiliated with

Also associated with

Rating

Defective adenoviruses and corresponding complementation lines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Defective adenoviruses and corresponding complementation lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Defective adenoviruses and corresponding complementation lines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-467407